International angiology : a journal of the International Union of Angiology
-
The aim of this study was to evaluate the immediate and long-term outcomes of endovascular treatment for massive hemoptysis and to identify the factors influencing outcome. ⋯ BAE and NBAE are safe and effective procedure for treatment for massive hemoptysis, with low recurrence and complication rates. Abnormal bronchial and nonbronchial systemic artery-pulmonary circulation shunts were usually found in many patients of tuberculosis and artery malformation. The better success rate was obtained by the bronchiectasis group, and ineffectiveness and high recurrence rate is associated with lung carcinoma.
-
Clinical presentation of pulmonary embolism (PE) comprises a wide spectrum from asymptomatic incidental finding to typical symptoms with chest pain, dyspnea, hemoptysis and syncope/collapse. We aimed to investigate typical symptoms of PE and increasing number of these symptoms to predict outcome in acute PE. ⋯ The symptom syncope/collapse is connected with poorer outcome in acute PE. An increasing number of symptoms failed to be useful for outcome prediction and risk stratification in acute PE.
-
Acute mesenteric ischemia (AMI) is a rapidly progressive disease where early diagnosis is life-saving. As a new cytokine, levels of thevisfatin might be affected during the ischema and reperfusion. In our study, we obtained changes of visfatin levels in the serum, peritoneal and intestinal lavage samples in rats, to investigate the effectiveness of these changes in the early diagnosis of AMI. ⋯ Serum, intestinal and peritoneal visfatin levels were increased not only in the case of mesenteric ischemia, but also in acute pancreatitis. In these two clinical pathologies, the visfatin levels of the intestinal and peritoneal cavitiesmay increase parallel to the serum visfatin levels.
-
Observational Study
Pycnogenol® and Centella asiatica in the management of asymptomatic atherosclerosis progression.
The aim of the study was to evaluate the effect of the nutritional supplements Pycnogenol® and total triterpenic fraction of Centella asiatica (TTFCA) on atherosclerosis progression in low-risk asymptomatic subjects with carotid or femoral stenosing plaques. ⋯ Pycnogenol® and the combination of Pycnogenol® +TTFCA appear to reduce the progression of subclinical arterial plaques and the progression to clinical stages. The reduction in plaque and clinical progression was associated with a reduction in oxidative stress. The results justify a large, randomized, controlled study to demonstrate the efficacy of the combined Pycnogenol® and TTFCA prophylactic therapy in preclinical atherosclerosis.